14 studies found for:    "congenital hyperinsulinism" OR "neonatal hyperinsulinism" OR "persistent hyperinsulinemic hypoglycemia" OR "familial hyperinsulinism"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
2 Recruiting Fluorodopa F 18 in Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Fluorodopa F 18
3 Unknown  Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
4 Completed Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: exendin-(9-39)
5 Completed Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
Condition: Non-focal Congenital Hyperinsulinism
Intervention: Procedure: restrictive pancreatic resection
6 Active, not recruiting Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism (CHI);   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
7 Available Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions: Hyperinsulinemic Hypoglycemia, Persistent;   Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
8 Recruiting Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
9 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
10 Completed Sandostatine® LP and Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Sandostatine LP
11 Available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism;   Beckwith-Wiedemann Syndrome;   Insulinoma
Intervention: Drug: 18F-DOPA
12 Not yet recruiting Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism
Condition: Conservatively Treated CHI Patients
13 Recruiting Sirolimus for the Treatment of Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: Sirolimus
14 Recruiting 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Conditions: Insulinoma;   Nesidioblastosis
Intervention: Drug: 68Ga-NOTA-exendin-4

Indicates status has not been verified in more than two years